http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006019965-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8d7b4b545594e1ca74244c0030f5245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb49e7bad4d3cb44dc93784a84091a1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_490dcf9e699632b2aeb82ec592da8a4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3122b28fe74de6d0d1cbf0498b33da4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df1c54a61d63d14bf8f87cb8a3d8d686
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2005-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a377744f41169581e7200ead8c0eb088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62133a6ff4011bcae10591a65c4a4514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bca38c440d2d441013695d92e6eb283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a4636d709c9990c41e0eb85335df1b0
publicationDate 2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006019965-A3
titleOfInvention Dipeptidyl peptidase inhibitors
abstract Compounds, pharmaceutical compositions, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a compound of formula (I) wherein R2 is amino (C1-6)alkyl, hetero(C3-12)cycloalkyl, hetero(C4-12)bicycloaryl, heteroaryl, or cyano; and W, X, Y, Z, R1, R5 and R7 are as defined herein.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101595109-B
priorityDate 2004-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004050658-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004018467-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25253
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID45031
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397492
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100301982
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1803
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13482
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281122

Total number of triples: 42.